Tepezza Lawsuit [December 2024 Update] | Tepezza Hearing Loss

The Tepezza Lawsuit is ongoing. 

A federal judge overseeing the Tepezza multidistrict litigation (MDL) has reprimanded both sides for improper conduct during depositions.

The litigation involves claims that Horizon Pharmaceuticals’ thyroid eye disease treatment, Tepezza, causes hearing loss.

Plaintiffs argue the company failed to disclose safety risks when seeking FDA approval and sold the drug despite knowledge of potential permanent harm.

In an order issued by U.S. Magistrate Judge M. David Weisman, requests for sanctions from both parties were denied.

Horizon accused plaintiffs’ counsel of canceling depositions without justification, while plaintiffs claimed Horizon’s legal team obstructed the process with overly aggressive objections.

Judge Weisman found fault with both sides, noting that each party incurred unnecessary costs due to the other’s actions.

The judge criticized plaintiffs’ attorneys for their approach during depositions, specifically for providing documents and calculations to assist witnesses in answering questions.

He also called out Horizon’s legal team for obstructive behavior, including inappropriate objections to foundational questions.

Judge Weisman warned that continued misconduct could result in reduced deposition time or even barring specific attorneys from further participation.

The MDL, centralized in the Northern District of Illinois, focuses on allegations that Tepezza was defectively designed and that Horizon failed to adequately warn about its risks.

The litigation highlights concerns about hearing loss linked to the drug, with plaintiffs seeking accountability for the alleged harm caused by the treatment.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.

The Tepezza Lawsuit is ongoing. 

The Tepezza Lawsuit involves claims that the drug, used for treating thyroid eye disease, has caused serious hearing-related side effects.

Plaintiffs argue that Horizon Therapeutics, the manufacturer, failed to properly warn patients and healthcare providers about the risks of hearing loss and tinnitus associated with Tepezza use.

In October, there were 178 cases filed in the Tepezza lawsuit, which increased slightly to 180 in November, adding 2 new cases.

Hearing loss and tinnitus can significantly affect daily life, making it difficult for those affected to maintain their quality of life and overall well-being.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.

The Tepezza Lawsuit  focuses on claims that the drug, used to treat thyroid eye disease, can cause permanent hearing loss and other serious auditory issues.

Plaintiffs argue that the manufacturers of Tepezza failed to provide adequate warnings about the risk of hearing damage, leaving patients unaware of the potential long-term effects.

In September, the Judicial Panel on Multidistrict Litigation (JPML) reported 173 active Tepezza lawsuits.

By October, the number of cases had increased to 178, signaling the addition of five cases.

Patients who have used Tepezza report experiencing hearing loss, tinnitus, and other auditory issues, which can have lasting effects on their quality of life.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.

The Tepezza Lawsuit, which involves claims that the drug Tepezza has caused serious hearing loss and other auditory issues in patients, continues to see an increase in case filings.

In August 2024, there were 150 active cases in the Tepezza lawsuit.

By September 2024, this number has grown to 173.

The increase in case numbers suggests growing awareness among patients about the potential risks associated with Tepezza, a medication primarily used to treat thyroid eye disease.

Plaintiffs in this lawsuit allege that Horizon Therapeutics, the manufacturer of Tepezza, failed to provide adequate warnings about the risk of hearing damage, which has had a profound impact on their quality of life.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.

The Tepezza Lawsuit is ongoing

The Tepezza Hearing Loss lawsuit involves claims against Horizon Therapeutics regarding the thyroid eye disease drug Tepezza.

Plaintiffs allege that Tepezza causes hearing loss and other auditory issues.

In July, there were 138 filings in the Tepezza Hearing Loss lawsuit.

By August, this number increased to 150 filings.

The rise in filings indicates growing awareness of the potential hearing-related side effects of Tepezza, prompting more individuals to seek legal recourse.

Tepezza, intended for treating thyroid eye disease, has been reported to cause hearing loss and tinnitus in some patients.

These auditory issues can significantly impact quality of life, leading affected individuals to file lawsuits against Horizon Therapeutics for failing to adequately warn about these risks.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.

Horizon Therapeutics Files Motion to Dismiss Tepezza Hearing Loss Bellwether Claims

Horizon Therapeutics recently moved to dismiss several claims in the Tepezza hearing loss bellwether trials within the federal MDL.

The MDL includes about 140 product liability lawsuits, alleging that Tepezza, a thyroid eye disease treatment, causes permanent hearing damage.

Horizon Therapeutics contends that the FDA’s approval of Tepezza’s label in January 2020 should preempt these claims.

They argue that the label warnings, approved by the FDA, were sufficient, and plaintiffs have not presented “newly acquired information” to support their claims.

Horizon seeks dismissal of 11 bellwether claims for lacking plausible strict liability or negligent design defect arguments. 

Nine claims are challenged on federal preemption grounds, and five are targeted for alleged fraudulent misrepresentation. 

In the MDL, Judge Thomas Durkin oversees coordinated discovery and early trial dates, intended to assess jury responses to the evidence and testimony.

Twelve bellwether cases have been selected for early trials, with the first scheduled for March 2026.

If the court does not dismiss all bellwether claims, discovery will continue, and the initial group of 12 claims will be narrowed to four for trial dates set in March, May, June, and August 2026.

These trials will help gauge the strengths and weaknesses of the allegations that Horizon failed to warn about the risk of hearing loss and did not instruct doctors to perform hearing tests during treatment.

The results of these bellwether trials will significantly impact settlement discussions, and If no resolution is reached post-trials, individual cases may be remanded for separate trial dates across U.S. District Courts.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free consultation today, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.

Quarterly mediation sessions for Tepezza hearing loss lawsuits will begin next month, as ordered by the court. 

These discussions aim to explore potential settlements and avoid numerous individual trials. 

Horizon Therapeutics faces nearly 140 product liability claims alleging failure to warn users about the risk of hearing loss associated with Tepezza (teprotonumab-trbw), a treatment for thyroid eye disease.

The number of claims is expected to grow, potentially reaching several hundred before the first trials in March 2026.

In July 2023, the FDA updated Tepezza’s prescribing information to include warnings about severe and permanent hearing loss.

The new label advises doctors to assess patients’ hearing before, during, and after Tepezza infusions, plaintiffs argue that earlier warnings could have prevented their permanent hearing loss.

A multidistrict litigation (MDL) was established last year, centralizing Tepezza lawsuits before U.S. District Judge Thomas Durkin in the Northern District of Illinois.

A bellwether program will see 12 representative cases undergo case-specific discovery, with early trials helping to predict jury responses to evidence and testimony.

The first bellwether trial is set for March 9, 2026, with additional trials every two months.

Magistrate Judge M. David Weisman ordered the commencement of quarterly Tepezza settlement talks starting on or about August 1.

These mediation sessions aim to reach a global settlement agreement, resolving many or all claims.

The parties will meet at least once every 90 days.

Core fact discovery is set to close on December 20, 2024, with the first four bellwether cases proposed by January 17, 2025.

The outcomes of bellwether trials will influence Tepezza settlement negotiations, impacting the potential compensation Horizon may need to pay.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free consultation today, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.

The Tepezza Hearing Loss Lawsuit is ongoing, and our lawyers are still accepting cases from those affected by hearing loss linked to the thyroid eye disease drug Tepezza. 

Tepezza Lawsuits involve claims of tinnitus, hearing loss, and other severe auditory problems resulting from the use of Tepezza.

The core arguments in the Tepezza Hearing Loss lawsuits involve:

• Failure to Warn: Plaintiffs argue that the manufacturers did not provide adequate warnings about the risk of hearing loss associated with Tepezza.

• Negligent Design: The formulation of Tepezza contributes to an increased risk of hearing issues, including tinnitus and permanent hearing loss.

• Lack of Adequate Instructions: Lawsuits claim that the manufacturers failed to provide proper instructions on how to mitigate the risk of hearing loss while using Tepezza.

Healthcare professionals recommend the following precautions for those using Tepezza:

• Monitor Auditory Health: Schedule regular hearing exams to detect and address any early signs of hearing issues.

• Report Symptoms Promptly: Immediately inform your healthcare provider if you experience tinnitus, hearing loss, or other auditory symptoms.

• Discuss with Your Doctor: Talk to your healthcare provider about the potential hearing risks and ways to mitigate them while undergoing treatment with Tepezza.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free consultation today, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.

The Tepezza Hearing Loss lawsuit is ongoing. 

The Tepezza Hearing Loss lawsuit involves claims that the thyroid eye disease medication Tepezza causes significant hearing loss in patients.

This lawsuit seeks to hold the manufacturer accountable for not adequately warning users of this serious side effect.

In June, there were 120 Tepezza Hearing Loss lawsuit filings.

By July, this number increased to 138, reflecting growing awareness of the risks associated with Tepezza.

Tepezza can cause hearing loss by damaging auditory nerves and ear structures, leading to tinnitus and permanent deafness.

These health issues have led more individuals to join the Tepezza Hearing Loss lawsuit.

The Tepezza Hearing Loss lawsuit aims to hold the manufacturer responsible for the harm caused by the medication.

Affected individuals should consult a Tepezza hearing loss lawyer to explore their legal options.

You may be eligible to file a Tepezza Lawsuit if you or a loved one took Tepezza and subsequently suffered permanent hearing loss or tinnitus.

Contact TorHoerman Law for a free legal consultation today, or use the chatbot on this page to see if you qualify for a Tepezza Lawsuit instantly.

The Tepezza Hearing Loss Lawsuit is ongoing and our lawyers continue to accept new clients. 

Federal Tepezza hearing loss litigation is progressing towards its first series of bellwether trials, scheduled between March 9, 2026, and August 24, 2026.

These trials will play a crucial role in shaping potential jury responses and advancing settlement discussions regarding claims against Tepezza’s parent company, Horizon Therapeutics.

Allegations central to the lawsuit accuse the pharmaceutical company of failing to sufficiently warn users about the risks of permanent and irreversible hearing loss associated with Tepezza, a treatment for thyroid eye disease.

The decision to push these cases to trial follows a preparatory period where U.S. District Judge Thomas Durkin, overseeing the multidistrict litigation (MDL) in the Northern District of Illinois, established a bellwether process.

This process involves a selection of 12 representative cases to undergo detailed discovery in anticipation of these early trial dates.

A deadline has been set for December 20, 2024, to conclude fact discovery for the 12 selected cases.

If you or a loved one took Tepezza and has subsequently suffered hearing loss (permanent loss or partial loss), tinnitus, or other hearing damage, you may be eligible to file a Tepezza Lawsuit.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.

The Tepezza Hearing Loss Lawsuit is ongoing and our lawyers continue to accept new clients. 

According to the latest updates from the Judicial Panel on Multidistrict Litigation (JPML), there are currently 120 Tepezza lawsuits consolidated in the Tepezza MDL, with seven new cases added since May 1st.

An increasing number of patients are filing claims after experiencing severe side effects from Tepezza, a medication used to treat Thyroid Eye Disease.

These lawsuits highlight concerns about hearing loss and other serious side effects linked to Tepezza.

Plaintiffs allege that they were not sufficiently informed about the potential risks associated with the treatment, leading to severe and unexpected health issues.

If you or a loved one took Tepezza and has subsequently suffered hearing loss (permanent loss or partial loss), tinnitus, or other hearing damage, you may be eligible to file a Tepezza Lawsuit.

Contact TorHoerman Law for a free consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.

The Tepezza Hearing Loss Lawsuit is ongoing and our lawyers continue to accept new clients. 

Tepezza, used for treating Thyroid Eye Disease, has been linked to serious side effects, including hearing loss and tinnitus.

Horizon Therapeutics, the manufacturer, faces allegations of not adequately warning patients about the potential risks of hearing impairment associated with Tepezza.

Patients have reported sudden or gradual hearing loss after starting treatment with Tepezza, which, in some cases, has been irreversible.

Tepezza potentially reduces the blood flow to the auditory system, damaging the inner ear’s hair cells essential for hearing.

This vascular effect can impair hearing, sometimes severely or irreversibly.

Key evidence in Tepezza hearing loss cases includes medical documentation of hearing conditions before and after Tepezza administration, audiometric test results, and records of Tepezza dosage and treatment duration.

Our Tepezza Lawyers estimate that the average Tepezza settlement may range between $75,000 and over 200,000 depending on individual circumstances and the direction of the litigation as a whole.

If you or a loved one took Tepezza and has subsequently suffered hearing loss (permanent loss or partial loss), tinnitus, or other hearing damage, you may be eligible to file a Tepezza Lawsuit.

Contact TorHoerman Law for a free legal consultation, or use the chatbot on this page to see if you qualify to file a Tepezza Lawsuit instantly.

The Tepezza lawsuit is ongoing. 

A total of 113 cases are pending in the Tepezza Marketing, Sales Practices, and Products Liability Litigation according to the most recent filings.

12 new cases were sent to the MDL in the past month.

The lawsuit claims that Tepezza causes serious side effects, including hearing loss and other auditory issues.

Tepezza is a treatment for thyroid eye disease.

Plaintiffs claim that Horizon Therapeutics, the manufacturer of Tepzza, failed to

adequately warn patients and healthcare providers about these potential risks.

If you or a loved one has suffered hearing loss or hearing as a result of Tepezza usage, contact us today for a free consultation. 

You can also use the chatbot on this page for an instant case evaluation.

The Tepezza litigation is progressing.

Per the most recent Judicial Panel on Multidistrict Litigation (JPML) filings, there are now 101 Tepezza lawsuits pending in the Tepezza MDL.

More and more patients are coming forward with claims of experiencing severe side effects after using Tepezza, a treatment for Thyroid Eye Disease.

Tepezza has been linked to hearing loss and other significant side effects, and has led to growing concerns among patients who have undergone treatment with this medication.

Tepezza Lawsuits claim that patients were not adequately warned about the potential risks associated with Tepezza, leading to unexpected and severe health complications.

For individuals who have used Tepezza and are now facing health issues, it’s important to consider seeking the help of a lawyer. 

Please reach out to our law firm for a free consultation. 

You can also use the chatbot on this page for a free case evaluation and to find out if you qualify for the Tepezza Lawsuit.

The Tepezza Lawsuit is ongoing. 

117 Tepezza Lawsuits were added to the MDL in the past month, growing from 8,217 (reported on Feb. 1) to 8,334 (reported on Mar. 1).

This spike in the number of Tepezza cases is reflective of the growing concern regarding potential harmful side effects associated with the use of the drug, which is used in the treatment of Thyroid Eye Disease (TED).

The Judicial Panel on Multidistrict Litigation (JPML) is closely monitoring this surge in legal actions against Horizon Therapeutics, the manufacturer of Tepezza.

The plaintiffs in the Tepezza Lawsuit allege that the company failed to adequately warn patients and healthcare providers about the possible risks and adverse effects of the drug, including hearing loss.

If you or a loved one have experienced any adverse effects after taking Tepezza, you may be eligible to participate in the Tepezza lawsuit. 

For more information and a free consultation, contact TorHoerman Law. 

You can also use the chatbot on this page for immediate assistance and to determine if you qualify for this lawsuit.

The Tepezza Litigation is ongoing and our lawyers are still accepting more cases.

As of February 2024, there are a total of 74 Tepezza Lawsuits pending according to the most recent JPML filings.

Tepezza Lawsuits are being consolidated into multidistrict litigation (MDL) under MDL 3079: Tepezza Marketing, Sales Practices, and Products Liability Litigation.

MDLs are legal procedures in the United States designed to handle multiple related civil lawsuits that involve similar issues, facts, or defendants.

When numerous individuals or entities file lawsuits related to a common set of circumstances, such as hearing loss resulting from Tepezza, these cases can be consolidated into a single federal district court for pretrial proceedings.

MDLs aim to streamline the litigation process by centralizing the discovery process, reducing duplication of efforts, and ensuring consistent rulings on key legal issues.

If you or a loved one used Tepezza and developed permanent hearing loss or other health problems, you may be eligible to file a Tepezza Lawsuit. 

Contact us for a free consultation or use the chatbot on this page to find out if you qualify for the Tepezza Lawsuit instantly.

The Tepezza Litigation is ongoing and our lawyers are still accepting new clients.

Currently, there are a total of 74 filings in the Tepezza Marketing, Sales Practices, and Products Liability Litigation, according to the most recent JPML filings published on January 2nd.

Tepezza Lawsuits for hearing loss are being consolidated into multidistrict litigation (MDL).

When numerous individuals have been injured in similar ways by the same product, drug, or accident, these cases can be consolidated into a single federal district court for pretrial proceedings.

MDLs aim to streamline the litigation process by centralizing the discovery process, reducing duplication of efforts, and ensuring consistent rulings on key legal issues.

Individuals who have developed hearing loss after using Tepezza are filing lawsuits, and the MDL offers a structured pathway to seek justice and compensation.

If you or a loved one used Tepezza and developed permanent hearing loss or other health problems, you may be eligible to file a Tepezza Lawsuit. 

Contact us for a free consultation or use the chatbot on this page to find out if you qualify for the Tepezza Lawsuit instantly.